History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea

다국어 초록 (Multilingual Abstract)

Neonatal respiratory distress syndrome (RDS) is a disease that is unique to newborn infants.
It is caused by a deficiency of pulmonary surfactant (PS), which is usually ready to be activated around the perinatal period. Until RDS was more clearly understood, it was not known why premature infants died from respiratory failure, although pathology revealed hyaline membranes in the alveoli. Surprisingly, the era of PS replacement therapy began only relatively recently. The first clinical trial investigating neonatal RDS was conducted in 1980. Since then, newborn survival has improved dramatically, which has led to significant advances in the field of neonatology. The present comprehensive review addresses PS, from its discovery to the application of artificial PS in newborns with RDS. It also reviews the history of PS in Korea, including its introduction, various commercial products, present and past research, newborn registries, and health insurance issues. Finally, it describes the inception of the Korean Society of Neonatology and future directions of research and treatment.

참고문헌 (Reference)

1 Bae CW, Korean Society of Neonatology c2013-, 2013

2 최중환, "한국에서 신생아 집중치료 역사의 이정표" 대한신생아학회 20 (20): 234-246, 2013

3 배종우, "한국 신생아학의 역사" 대한의사협회 59 (59): 490-497, 2016

4 배종우, "신생아 호흡곤란 증후군에서 인공 폐 표면활성제 보충요법 제 3보고 : 지난 15년간 한국에서의 치료 결과" 대한소아청소년과학회 47 (47): 940-948, 2004

5 고지원, "Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants" 대한소아청소년과학회 61 (61): 315-321, 2018

6 MacKlin CC, "The pulmonary alveolar mucoid film and the pneumonocytes" 266 (266): 1099-1104, 1954

7 Cochrane CG, "The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome" 153 (153): 404-410, 1996

8 Almlén A, "Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits" 98 (98): 91-99, 2010

9 Halliday HL, "Surfactants: past, present and future" 28 (28): S47-S56, 2008

10 Kattwinkel J, "Surfactant. Evolving issues" 25 (25): 17-32, 1998

11 Bae CW, "Surfactant replacement therapy in neonates with respiratory distress syndrome : a collective evaluation of trials from 16 hospitals" 36 (36): 244-265, 1993

12 Park CO, "Surfactant replacement therapy in neonatal respiratory distress syndrome" 34 (34): 1211-1222, 1991

13 Bae CW, "Surfactant replacement therapy in RDS : a collaborative study of multi-center trials in Korea" 4 (4): 124-135, 1997

14 Stevens TP, "Surfactant replacement therapy" 131 (131): 1577-1582, 2007

15 Niemarkt HJ, "Surfactant for respiratory distress syndrome : new ideas on a familiar drug with innovative applications" 111 (111): 408-414, 2017

16 배종우, "Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years" 대한의학회 24 (24): 1110-1118, 2009

17 Gruenwald P, "Surface tension as a factor in the resistance of neonatal lungs to aeration" 53 (53): 996-1007, 1947

18 Avery ME, "Surface properties in relation to atelectasis and hyaline membrane disease" 97 (97): 517-523, 1959

19 한원호, "Recent Trends in Neonatal Mortality in Very Low Birth Weight Korean Infants: In Comparison with Japan and the USA" 대한의학회 26 (26): 467-473, 2011

20 Robertson B, "Principles of surfactant replacement" 1408 (1408): 346-361, 1998

21 Wiseman LR, "Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome" 48 (48): 386-403, 1994

22 Kribs A, "Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial" 169 (169): 723-730, 2015

23 Neergaard K, "Neue auffassungen über einen grundbegriff der atemmechanik" 66 (66): 373-394, 1929

24 Chu J, "Neonatal pulmonary ischemia. I. Clinical and physiological studies" 40 (40): 709-782, 1967

25 Enhörning G, "Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant" 50 (50): 58-66, 1972

26 Prange HD, "Laplace's law and the alveolus: a misconception of anatomy and a misapplication of physics" 27 (27): 34-40, 2003

27 Hallman M, "Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome" 71 (71): 473-482, 1983

28 King RJ, "Isolation of apoproteins from canine surface active material" 224 (224): 788-795, 1973

29 Thannhauser SJ, "Isolation and properties of hydrolecithin(dipalmityl lecithin)from lung; its occurrence in the sphingomyelin fraction of animal tissues" 166 (166): 669-675, 1946

30 정성훈, "Improvement in the Survival Rates of Very Low Birth Weight Infants after the Establishment of the Korean Neonatal Network: Comparison between the 2000s and 2010s" 대한의학회 32 (32): 1228-1234, 2017

31 The Korean Society of Neonatology, "History of the Korean Society of Neonatology"

32 Obladen M, "History of surfactant up to 1980" 87 (87): 308-316, 2005

33 Namgung R, "Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants" 30 (30): 355-366, 1989

34 Adams FH, "Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings" 12 (12): 841-848, 1978

35 Häfner D, "Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury" 12 (12): 193-201, 1999

36 김성미, "Early Prophylactic versus Late Selective Use of Surfactant for Respiratory Distress Syndrome in Very Preterm Infants: A Collaborative Study of 53 Multi-Center Trials in Korea" 대한의학회 29 (29): 1126-1131, 2014

37 배종우, "Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties" 연세대학교의과대학 57 (57): 203-208, 2016

38 Clements JA, "Dependence of pressure-volume characteristics of lungs on intrinsic surface active material" 187 : 592-, 1956

39 Singh N, "Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants" (12) : CD010249-, 2015

40 Moon Young Seo, "Clinical Outcomes of Minimally Invasive Surfactant Therapy via Tracheal Catheterization in Neonates with a Gestational Age of 30 Weeks or More Diagnosed with Respiratory Distress Syndrome" 대한신생아학회 25 (25): 109-117, 2018

41 Shim JW, "Changes in survival rate for very-low-birth-weight infants in Korea: comparison with other countries" 30 (30): S25-S34, 2015

42 Fujiwara T, "Artificial surfactant therapy in hyaline-membrane disease" 1 (1): 55-59, 1980

43 최용성, "A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments" 연세대학교의과대학 58 (58): 823-828, 2017

44 배종우, "2010년 전국 72개 병원에서 신생아 호흡곤란증후군의 폐 표면활 성제 치료 결과: 지난 20년간의 비교" 대한신생아학회 18 (18): 409-411, 2011